INTERACTION OF C-TERMINAL SEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE WITH TEMPLATE PRIMER

被引:0
|
作者
DEVICO, AL
COPELAND, TD
OROSZLAN, S
GALLO, RC
SARNGADHARAN, MG
机构
[1] NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MOLEC VIROL & CARCINOGENESIS LAB,FREDERICK,MD 21702
[2] NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have raised a rabbit monospecific antibody (designated C2003) against a synthetic peptide (CTP66) derived from a conserved sequence in the C-terminal portion of the p66 component of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) (DeVico, A. L., Copeland, T. D., Veronese, F. D., Oroszlan, S., Gallo, R. C., and Sarngadharan, M. G. (1989) AIDS Res. Hum. Retroviruses 5, 51-60). This antibody directly inhibits the polymerase activity of HIV-1 RT and of RTs from a variety of retroviruses. HIV-1 RT is protected from this inhibition by preincubation of the enzyme with template primer prior to treatment with the antibody. Such protection is abrogated when the pretreatment is conducted under conditions of high ionic strength. Kinetic studies showed that the antibody-mediated inhibition is competitive with respect to template primer concentration. These results indicate that C2003 antibody acts to interfere with the template binding function of the enzyme and further indicates that conserved residues recognized by the antibody may be directly involved in this function.
引用
收藏
页码:6774 / 6779
页数:6
相关论文
共 50 条
  • [21] HALOACETAMIDOTHYMIDINES AS POTENTIAL AFFINITY LABELS OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    NEENAN, JP
    SNYDER, MJ
    NELLIS, JA
    ADAMS, EW
    FASEB JOURNAL, 1995, 9 (06): : A1279 - A1279
  • [22] AFFINITY MODIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE AND DNA-TEMPLATE BY PHOTOREACTIVE DCTP ANALOGS
    DORONIN, SV
    DOBRIKOV, MI
    BUCKLE, M
    ROUX, P
    BUC, H
    LAVRIK, OI
    FEBS LETTERS, 1994, 354 (02) : 200 - 202
  • [23] ACTIVE-SITE STUDIES OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    MITCHELL, LLW
    COOPERMAN, BS
    BIOCHEMISTRY, 1992, 31 (33) : 7707 - 7713
  • [24] ANTI-(HUMAN IMMUNODEFICIENCY VIRUS) ACTIVITY OF POLYOXOTUNGSTATES AND THEIR INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    MOORE, PS
    JONES, CJ
    MAHMOOD, N
    EVANS, IG
    GOFF, M
    COOPER, R
    HAY, AJ
    BIOCHEMICAL JOURNAL, 1995, 307 : 129 - 134
  • [25] Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity
    DeStefano, JJ
    Cristofaro, JV
    NUCLEIC ACIDS RESEARCH, 2006, 34 (01) : 130 - 139
  • [26] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - AFFINITY LABELING OF THE PRIMER BINDING-SITE
    MITINA, RL
    DORONIN, SV
    DOBRIKOV, MI
    TABATADZE, DR
    LEVINA, AS
    LAVRIK, OI
    FEBS LETTERS, 1992, 312 (2-3) : 249 - 251
  • [27] ANTIBODY THAT INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE AND ASSOCIATION WITH INABILITY TO ISOLATE VIRUS
    SANO, K
    LEE, MH
    MORALES, F
    NISHANIAN, P
    FAHEY, J
    DETELS, R
    IMAGAWA, DT
    JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (12) : 2415 - 2417
  • [28] REGULATION OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY DNTPS
    WEST, AB
    ROBERTS, TM
    KOLODNER, RD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) : 9720 - 9724
  • [29] TEA POLYPHENOLS AS A NOVEL CLASS OF INHIBITORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    NAKANE, H
    HARA, Y
    ONO, K
    FOOD PHYTOCHEMICALS FOR CANCER PREVENTION II: TEAS, SPICES, AND HERBS, 1994, 547 : 56 - 64
  • [30] CASSETTE MUTAGENESIS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BOYER, PL
    FERRIS, AL
    HUGHES, SH
    JOURNAL OF VIROLOGY, 1992, 66 (02) : 1031 - 1039